Clinical Trial Update: Camrelizumab Combined with Apatinib Mesylate Tablets, Nab-paclitaxel and S-1 in the Treatment of Locally Advanced Gastric Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating camrelizumab in combination with apatinib, nab-paclitaxel, and S-1 for locally advanced gastric cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Apatinib (apatinib)
• Camrelizumab (camrelizumab)
• Nab-paclitaxel (paclitaxel protein-bound)
• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Fujian Medical University | Conditions: Advanced Gastric Cancer | Phase 2 | Status: COMPLETED